VRTX34:BVMF
Vertex Pharmaceuticals Inc BDR
R$85.77
arrow_downward
-0.52%(-0.45) 1D
Sep 29, 11:04:04 AM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX34...
Open
R$85.77
High
R$85.77
Low
R$85.77
Mkt. cap
132.20B
Avg. vol.
511.00
Volume
11.00
52-wk high
R$89.01
52-wk low
R$65.18
Shares outstanding
253.46M
No. of employees
6K
Open
R$85.77
High
R$85.77
Low
R$85.77
Mkt. cap
132.20B
Avg. vol.
511.00
Volume
11.00
52-wk high
R$89.01
52-wk low
R$65.18
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
Seeking Alpha
·
2 hours ago
Vertex Pharmaceuticals- Still Too Much Emphasis On CF Supremacy - I Foresee A Downgrade
The Motley Fool
·
5 hours ago
2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.
AD HOC NEWS
·
19 hours ago
Vertex Pharmaceuticals stock last trades at USD 526.66 on September 28, 2026
Yahoo Finance
·
20 hours ago
Vertex Pharmaceuticals Incorpor (VRTX) Stock Forecasts
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc BDR
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com